InvestSMART

BLS Pharmaceuticals Limited (ASX: BLS) - Announcements

Current share price for BLS : $0.965 0.06 (5.85%)+

ASX company news and announcements for BLS Pharmaceuticals Limited (BLS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All BLS Pharmaceuticals Limited (BLS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than BLS Pharmaceuticals Limited (BLS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for BLS Pharmaceuticals Limited (BLS)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$228 Projects Completed & New Agreements Signed 17 May 2007 8:28AM $0.110 $0.965 risen by 777.27%
$228 Commitments Test Entity - Third Quarter Report 26 Apr 2007 5:56PM n/a $0.965 n/a
$228 Working with Cardinal Bioresearch 4 Apr 2007 9:01AM n/a $0.965 n/a
$228 Collaboration with Cleveland Biosensors 12 Mar 2007 9:43AM $0.125 $0.965 risen by 672%
$228 Half Yearly Report/Half Year Accounts 1 Mar 2007 8:25AM $0.120 $0.965 risen by 704.17%
$228 US Patent Granted 14 Feb 2007 9:53AM n/a $0.965 n/a
$228 Commitments Test Entity - Second Quarter Report 31 Jan 2007 3:57PM n/a $0.965 n/a
$228 Starts research project with Beckman Coulter 29 Jan 2007 9:46AM $0.190 $0.965 risen by 407.89%
$228 Gains traction in IVD market 15 Jan 2007 10:05AM $0.155 $0.965 risen by 522.58%
$228 Raises Funds from Major Shareholders 22 Dec 2006 11:38AM n/a $0.965 n/a
$228 Awarded $2.69m AusIndustry Grant 11 Dec 2006 1:16PM $0.140 $0.965 risen by 589.29%
$228 Commitments Test Entity - First Quarter Report 31 Oct 2006 11:49AM $0.170 $0.965 risen by 467.65%
$228 Preliminary Final Report 13 Sep 2006 4:00PM n/a $0.965 n/a
$228 Response to ASX Query 14 Aug 2006 9:29AM n/a $0.965 n/a
$228 Enters into agreement with US company Multiplex Biosciences 10 Aug 2006 4:08PM $0.130 $0.965 risen by 642.31%
$228 Commitments Test Entity - Fourth Quarter Report 31 Jul 2006 10:54AM $0.170 $0.965 risen by 467.65%
$228 BLS & the IMB awarded $800 000 grant 18 Apr 2006 9:07AM $0.220 $0.965 risen by 338.64%
$228 Commitments Test Entity - Third Quarter Report 6 Apr 2006 2:39PM n/a $0.965 n/a
$228 Half Yearly Report & Half Year Accounts 16 Mar 2006 3:31PM $0.185 $0.965 risen by 421.62%
$228 Appointment of new CEO 10 Mar 2006 12:21PM $0.200 $0.965 risen by 382.50%
$228 Trading Halt 10 Mar 2006 12:02PM $0.200 $0.965 risen by 382.50%
$228 Commitments Test Entity - Second Quarter Report 30 Jan 2006 4:06PM n/a $0.965 n/a

51 - 72 of 72 results

Page 3 of 3

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.